此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

Social Prescribing for a Mindful Lifestyle

2026年6月21日 更新者：Buddhist Tzu Chi General Hospital

The goal of this clinical trial is to evaluate the effectiveness of an 8-week mindfulness lifestyle social prescribing program in community-dwelling older adults aged 55 and older. The main questions it aims to answer are:

To establish a mindfulness lifestyle social prescribing model applied to the psychological and social health promotion of middle-aged and older populations.

To evaluate the effectiveness of the intervention on improving depressive symptoms, loneliness, and quality of life in this population.

Participants will receive an 8-week group intervention program, with each weekly session lasting approximately 3 hours. The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing). Researchers will collect and evaluate data from pre- and post-intervention assessments to measure changes in depressive symptoms, loneliness risk, and overall quality of life.

研究概览

地位

尚未招聘

条件

干预/治疗

详细说明

This clinical trial implements an 8-week mindfulness lifestyle social prescribing program designed to enhance the psychological and social well-being of community-dwelling older adults. The intervention integrates mindfulness practices with healthy lifestyle modifications to address sub-healthy states, such as depressive symptoms and social isolation, which traditional clinical models often fail to fully resolve.

The structured 8-week group curriculum meets weekly for 3 hours per session. The program systematically incorporates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (including herbal therapy and leaf printing).

The program is delivered by a multidisciplinary team of geriatricians, geriatric case managers, nutritionists, exercise instructors, and trained volunteers to ensure comprehensive support.

Research procedures involve a pre- and post-intervention assessment design. Participants will undergo standardized evaluations before the commencement of the first session (Week 1) and upon the completion of the program (Week 8). These assessments will objectively measure changes in depressive symptoms, the risk of loneliness, and overall quality of life to determine the effect of this social prescribing model.

研究类型

介入性

注册 (估计的)

50

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习联系方式

学习地点

  • 台湾
    • Taiwan
      • Hualien City、Taiwan、台湾、97071
        • Buddhist Tzu Chi General Hospital
        • 接触：

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • People aged 55 years or older.
  • People with a Geriatric Depression Scale (GDS-15) score of 7-10 or a UCLA Loneliness Scale Version 3 score of 35-64.
  • People can understand the research process, meet the requirements of the research, and can sign the informed consent and participate in the project.

Exclusion Criteria:

  • People that are unable to cooperate with the project or follow-up.
  • According to the PI's judgment, people with severe or poorly controlled conditions include ongoing acute diseases, severe infections, severe abnormal laboratory tests, or serious medical conditions with the following systems: cardiovascular, pulmonary, hepatic, nervous, mental, metabolic, renal, musculoskeletal, gastrointestinal, etc.
  • People with severe depression, risk of self-harm, severe cognitive impairment (dementia), visual or hearing impairment, and disabilities that prevent the completion of the project and assessment.
  • People are currently or expected to join any other physical training courses or nutrition intervention plans during the project period.
  • Others are based on the judgment of the PI that participating in this project may adversely affect the safety of the subjects, hinder the progress of the experiment, or interfere with the evaluation of the outcomes of the project.

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

  • 主要用途：卫生服务研究
  • 分配：不适用
  • 介入模型：单组作业
  • 屏蔽：无（打开标签）

武器和干预

参与者组/臂
干预/治疗
实验性的：实验臂
行为的：Mindfulness Lifestyle Social Prescribing Program
An 8-week, once-weekly, 3-hour group program designed for middle-aged and older adults. The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing). It is delivered by a multidisciplinary team including geriatricians, case managers, dietitians, exercise instructors, and volunteers.

研究衡量的是什么？

主要结果指标

结果测量
措施说明
大体时间
Changes in Geriatric Depression Scale (GDS-15) score
大体时间：Baseline and Week 8
The Geriatric Depression Scale (GDS-15) is a 15-item questionnaire used to assess depression symptoms in older adults. Scores range from 0 to 15, with higher scores indicating more severe depressive symptoms.
Baseline and Week 8
Changes in UCLA Loneliness Scale score
大体时间：Baseline and Week 8
The UCLA Loneliness Scale measures an individual's subjective feelings of loneliness and social isolation. Scores range from 20 to 80, with higher scores indicating greater loneliness.
Baseline and Week 8
Changes in WHOQOL-BREF questionnaire score
大体时间：Baseline and Week 8
The World Health Organization Quality of Life-BREF (WHOQOL-BREF) Taiwan version is a 28-item questionnaire used to assess the physical, psychological, social relationships, and environment domains of quality of life. Scores for each domain are transformed to a scale of 4 to 20, with higher scores indicating better quality of life. Changes in scores were evaluated between baseline and week 8.
Baseline and Week 8

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

Buddhist Tzu Chi General Hospital

调查人员

  • 首席研究员：Sheng-Lun Kao, MD. PhD.、Buddhist Tzu Chi General Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年7月1日

初级完成 (估计的)

2028年12月31日

研究完成 (估计的)

2028年12月31日

研究注册日期

首次提交

2026年6月21日

首先提交符合 QC 标准的

2026年6月21日

首次发布 (实际的)

2026年6月25日

研究记录更新

最后更新发布 (实际的)

2026年6月25日

上次提交的符合 QC 标准的更新

2026年6月21日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • IRB115-107-A

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)？

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

订阅